Literature DB >> 36003867

Commentary: Tricuspid repair-why the hesitation?

Heidi B Nafday1, Eugene A Grossi1.   

Abstract

Entities:  

Year:  2020        PMID: 36003867      PMCID: PMC9390464          DOI: 10.1016/j.xjon.2020.06.001

Source DB:  PubMed          Journal:  JTCVS Open        ISSN: 2666-2736


× No keyword cloud information.
Heidi B. Nafday, MD, and Eugene A. Grossi, MD Surgeons may hesitate to repair functional tricuspid regurgitation at time of mitral intervention if reluctant to extend operative time, particularly when less experienced with mitral valve repair. See Article page 52. Functional tricuspid regurgitation is unusual among valvular lesions in that it may improve, stabilize, or worsen after mitral valve repair or replacement. Historically, this has created a debate over the indications for intervention and best approach. In their excellent review, Chikwe and Megna delineate the rationale and indications for tricuspid valve repair at the time of mitral intervention in patients with moderate or greater regurgitation or annular dilatation and contend that superior long-term clinical outcomes are attainable when repair is performed when indicated by American Heart Association and European Society of Cardiology consensus guideline recommendations. Despite those recommendations, rates of concomitant repair remain relatively low at 15.8%. Why is this the case when most tricuspid repairs can be performed relatively quickly and without significant technical difficulty or morbidity? There are several examples in cardiac surgery where societal recommendations do not always correspond with practice patterns. For example, rates of multiple arterial grafts during coronary bypass remain low despite evidence of superior long-term survival and modified maze procedures for atrial fibrillation in patients undergoing concomitant mitral valve surgery., In these cases, surgeons often argue that despite understanding those recommendations, when faced with an individual patient, the surgery is tailored for additional considerations. For example, a patient with obesity or diabetes may be selected to not undergo bilateral mammary grafting for concern of developing a sternal wound infection, or there may be questionable benefit in more elderly patients. Similarly, surgeons may be concerned about the incremental risk of adding tricuspid repair to mitral surgery or the risk of heart block. As discussed by Chikwe and Megna, those risks may be overestimated and decreasing in more recent cohort studies. Most surgeons have unfortunately experienced untoward outcomes in patients undergoing multiple valve interventions despite sound planning and good surgical technique and perioperative management. While the Society of Thoracic Surgeons predicted mortality risk for mitral repair or replacement is not increased with the addition of tricuspid repair, there is an incremental increase in the risk of morbidity with severity of tricuspid regurgitation. Although these unfortunate outcomes may be the exception, the surgeon will reflect on what could have been done differently to prevent a patient's death. When no obvious answer is apparent—such as inadequate cardioplegic protection or poor ventricular function—longer operative bypass and crossclamp times are often blamed. Moving forward, when a similar patient presents for surgery, the surgeon may hesitate to proceed with tricuspid repair for moderate regurgitation or with borderline annular dilatation. This hesitancy to extend an operation is compounded by the significant number of surgeons with low annual volume of mitral procedures. At last year's Transcatheter Cardiovascular Therapeutics meeting, analysis of linked Society of Thoracic Surgeons and Centers for Medicare and Medicaid Services databases again demonstrated that one half of the cardiac surgeons in this country perform 5 or fewer mitral repairs per annum. In addition, when comparing by surgical volume the lower- to upper-quartile centers, there were significant differences with increased mortality (odds ratio [OR], 2.1), morbidity (OR, 1.35) and 1-year mortality (OR, 1.6) all observed in the lower-volume centers! This editorial elegantly organizes the benefits and techniques of concomitant tricuspid repair for the cardiac surgical community. Unfortunately, what remains unspoken is the major problem of a relative lack of experienced surgeons for the primary mitral valve repair, which does negatively impact outcomes. Experience in primary mitral repair needs to be bolstered for a great majority of surgeons to extend the operation to concomitant tricuspid repair.
  3 in total

1.  Incremental risk of the Cox-maze IV procedure for patients with atrial fibrillation undergoing mitral valve surgery.

Authors:  Lindsey L Saint; Ralph J Damiano; Phillip S Cuculich; Tracey J Guthrie; Marc R Moon; Nabil A Munfakh; Hersh S Maniar
Journal:  J Thorac Cardiovasc Surg       Date:  2013-08-30       Impact factor: 5.209

2.  Multiple Versus Single Arterial Coronary Bypass Graft Surgery for Multivessel Disease.

Authors:  Zaza Samadashvili; Thoralf M Sundt; Andrew Wechsler; Joanna Chikwe; David H Adams; Craig R Smith; Desmond Jordan; Leonard Girardi; Stephen J Lahey; Jeffrey P Gold; Mohammed H Ashraf; Edward L Hannan
Journal:  J Am Coll Cardiol       Date:  2019-09-10       Impact factor: 24.094

3.  The Society of Thoracic Surgeons Mitral Repair/Replacement Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force.

Authors:  Vinay Badhwar; J Scott Rankin; Xia He; Jeffrey P Jacobs; James S Gammie; Anthony P Furnary; Frank L Fazzalari; Jane Han; Sean M O'Brien; David M Shahian
Journal:  Ann Thorac Surg       Date:  2015-12-28       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.